Section 1927 requires drug
manufactures to enter into and have in effect a rebate agreement
with the Federal Government for States to receive funding for drugs
dispensed to Medicaid recipients. In order for payment to be made
under Medicaid, the drug labeler must complete and sign a drug
rebate agreement and fillin the information on the related
documents. The Affordable Care Act (ACA) added two new data
elements to potentially be reported by manufacturers, a Pediatric
Exclusivity product indicator and a new optional "ACA base AMP"
field. Additionally, per the ACA, the Federal upper limit (FUL)
will be calculated as no less than 175 percent of the weighted
average of the most recently reported monthly AMP. Section 1927 of
the Act requires manufacturers to report the total number of units
that are used to calculate monthly AMP for each covered outpatient
drug no later than 30 days after the last day of the month. We plan
to require manufacturers to report these units by the same unit
type used to calculate the AMP and to use these units to calculate
the weighted-AMP-based FULs prices.
Statute at
Large: 19
Stat. 1927 Name of Statute: null
The number of manufacturers has
risen from 540 to 580; therefore, the annual hour burden has risen.
The three new fields will not result in an additional reporting
burden. The first is so minimal that it is not quantifiable, and
the second is an optional, one-time entry that may be made on-line.
The manufacturer units are already tracked by manufacturers as they
are used to calculate the monthly AMP. Manufacturers have stated
that there would not be an ongoing burden to submit after systems
changes are incorporated.
$750,000
No
No
Yes
No
No
Uncollected
Melissa Musotto
4107866962
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.